Literature DB >> 26096624

Assessment of Cardiac Function by Echocardiography.

Moses Mathur1, Hayan Al Maluli, Pravin Patil.   

Abstract

OPINION STATEMENT: Accurate assessment of cardiac function by transthoracic echocardiography (TTE) plays an essential role in clinical cardiology. While left ventricular ejection fraction (LVEF) assessment has traditionally been the most commonly used objective echocardiographic marker, many other echocardiographic parameters exist that permit an enhanced understanding of cardiac function. These range from 2-dimensional (2D) and 3-dimensional (3D) morphologic parameters to functional parameters such as wall strain and myocardial performance index. In this review, we survey a variety of TTE-based techniques that are utilized in practice to assess the systolic cardiac function of both the left and right ventricles.

Year:  2015        PMID: 26096624     DOI: 10.1007/s11936-015-0397-7

Source DB:  PubMed          Journal:  Curr Treat Options Cardiovasc Med        ISSN: 1092-8464


  24 in total

Review 1.  Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association.

Authors:  Manuel D Cerqueira; Neil J Weissman; Vasken Dilsizian; Alice K Jacobs; Sanjiv Kaul; Warren K Laskey; Dudley J Pennell; John A Rumberger; Thomas Ryan; Mario S Verani
Journal:  Circulation       Date:  2002-01-29       Impact factor: 29.690

2.  Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography.

Authors:  Lawrence G Rudski; Wyman W Lai; Jonathan Afilalo; Lanqi Hua; Mark D Handschumacher; Krishnaswamy Chandrasekaran; Scott D Solomon; Eric K Louie; Nelson B Schiller
Journal:  J Am Soc Echocardiogr       Date:  2010-07       Impact factor: 5.251

3.  Longitudinal shortening accounts for the majority of right ventricular contraction and improves after pulmonary vasodilator therapy in normal subjects and patients with pulmonary arterial hypertension.

Authors:  Suzanne B Brown; Amresh Raina; David Katz; Molly Szerlip; Susan E Wiegers; Paul R Forfia
Journal:  Chest       Date:  2010-11-24       Impact factor: 9.410

4.  Correlation of tricuspid annular velocities with invasive hemodynamics in pulmonary hypertension.

Authors:  Navin Rajagopalan; Neil Saxena; Marc A Simon; Kathy Edelman; Michael A Mathier; Angel López-Candales
Journal:  Congest Heart Fail       Date:  2007 Jul-Aug

Review 5.  3D echocardiography: a review of the current status and future directions.

Authors:  Judy Hung; Roberto Lang; Frank Flachskampf; Stanton K Shernan; Marti L McCulloch; David B Adams; James Thomas; Mani Vannan; Thomas Ryan
Journal:  J Am Soc Echocardiogr       Date:  2007-03       Impact factor: 5.251

6.  Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.

Authors:  Arthur J Moss; Wojciech Zareba; W Jackson Hall; Helmut Klein; David J Wilber; David S Cannom; James P Daubert; Steven L Higgins; Mary W Brown; Mark L Andrews
Journal:  N Engl J Med       Date:  2002-03-19       Impact factor: 91.245

7.  An abnormal right ventricular apical angle is indicative of global right ventricular impairment.

Authors:  Angel López-Candales; Kaoru Dohi; Anca Iliescu; Ross C Peterson; Kathy Edelman; Raveen Bazaz
Journal:  Echocardiography       Date:  2006-05       Impact factor: 1.724

Review 8.  Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms.

Authors:  N B Schiller; P M Shah; M Crawford; A DeMaria; R Devereux; H Feigenbaum; H Gutgesell; N Reichek; D Sahn; I Schnittger
Journal:  J Am Soc Echocardiogr       Date:  1989 Sep-Oct       Impact factor: 5.251

9.  Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.

Authors:  Gust H Bardy; Kerry L Lee; Daniel B Mark; Jeanne E Poole; Douglas L Packer; Robin Boineau; Michael Domanski; Charles Troutman; Jill Anderson; George Johnson; Steven E McNulty; Nancy Clapp-Channing; Linda D Davidson-Ray; Elizabeth S Fraulo; Daniel P Fishbein; Richard M Luceri; John H Ip
Journal:  N Engl J Med       Date:  2005-01-20       Impact factor: 91.245

10.  Use of a regional wall motion score to enhance risk stratification of patients receiving an implantable cardioverter-defibrillator.

Authors:  S Nath; W A DeLacey; D E Haines; V A Berry; M J Barber; I L Kron; J P DiMarco
Journal:  J Am Coll Cardiol       Date:  1993-10       Impact factor: 24.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.